# Ketohexokinase Inhibition in Hereditary Fructose Intolerance

> **NCT06089265** · PHASE2 · COMPLETED · sponsor: **Maastricht University Medical Center** · enrollment: 8 (actual)

## Conditions studied

- HFI

## Interventions

- **DRUG:** PF-06801591

## Key facts

- **NCT ID:** NCT06089265
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-15
- **Primary completion:** 2023-11-30
- **Final completion:** 2023-11-30
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2024-01-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06089265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06089265, "Ketohexokinase Inhibition in Hereditary Fructose Intolerance". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06089265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*